Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.

PubWeight™: 4.47‹?› | Rank: Top 1%

🔗 View Article (PMID 22443478)

Published in N Engl J Med on March 26, 2012

Authors

Raj R Makkar1, Gregory P Fontana, Hasan Jilaihawi, Samir Kapadia, Augusto D Pichard, Pamela S Douglas, Vinod H Thourani, Vasilis C Babaliaros, John G Webb, Howard C Herrmann, Joseph E Bavaria, Susheel Kodali, David L Brown, Bruce Bowers, Todd M Dewey, Lars G Svensson, Murat Tuzcu, Jeffrey W Moses, Matthew R Williams, Robert J Siegel, Jodi J Akin, William N Anderson, Stuart Pocock, Craig R Smith, Martin B Leon, PARTNER Trial Investigators

Author Affiliations

1: Cedars-Sinai Heart Institute, Los Angeles, USA.

Associated clinical trials:

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER) | NCT00530894

Platelet Reactivity After TAVI: A Multicenter Pilot Study (REAC-TAVI) | NCT02224066

Use of Cardiac-MRI to Predict Results for People With Severe Aortic Stenosis | NCT01905852

Articles citing this

(truncated to the top 100)

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement. J Thorac Cardiovasc Surg (2015) 2.04

Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals. Neth Heart J (2014) 1.85

Stroke after aortic valve surgery: results from a prospective cohort. Circulation (2014) 1.80

Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79

Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol (2014) 1.64

Single center TAVR experience with a focus on the prevention and management of catastrophic complications. Catheter Cardiovasc Interv (2014) 1.43

Current management of calcific aortic stenosis. Circ Res (2013) 1.18

Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol (2015) 1.08

Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv (2014) 1.04

Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol (2013) 1.03

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart (2014) 1.02

Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol (2013) 0.98

Changes in the practice of cardiology: therapies at the forefront of science. Singapore Med J (2016) 0.97

Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv (2015) 0.95

Toward optimization of a novel trileaflet polymeric prosthetic heart valve via device thrombogenicity emulation. ASAIO J (2013) 0.88

Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med (2014) 0.87

Beyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement. Curr Cardiol Rev (2013) 0.87

Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart (2013) 0.86

Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up. Singapore Med J (2016) 0.86

A review of most relevant complications of transcatheter aortic valve implantation. ISRN Cardiol (2013) 0.84

Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment. Interact Cardiovasc Thorac Surg (2013) 0.83

Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure. Clin Res Cardiol (2014) 0.81

Staged balloon aortic valvuloplasty before standard aortic valve replacement in selected patients with severe aortic valve stenosis. Tex Heart Inst J (2014) 0.81

Transcatheter aortic valve implantation (TAVI): the hype and the hope. Tex Heart Inst J (2013) 0.81

Transcatheter aortic valve implantation in the elderly: who to refer? Prog Cardiovasc Dis (2014) 0.81

Validation of transcatheter aortic valve implantation risk scores in relation to early and mid-term survival: a single-centre study. Interact Cardiovasc Thorac Surg (2015) 0.81

Aortic Stenosis: Changing Disease Concepts. J Cardiovasc Ultrasound (2015) 0.81

Predictive factors for pacemaker requirement after transcatheter aortic valve implantation. BMC Cardiovasc Disord (2012) 0.81

Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. Cardiovasc Diagn Ther (2013) 0.81

Diagnosis and management of valvular aortic stenosis. Clin Med Insights Cardiol (2014) 0.80

The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol (2015) 0.80

The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study. J Cardiovasc Magn Reson (2014) 0.80

Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation. Open Heart (2016) 0.80

Transcatheter aortic valve implantation. Surg Today (2014) 0.80

Early and intermediate survival after transcatheter aortic valve implantation: systematic review and meta-analysis of 14 studies. BMJ Open (2013) 0.79

Calcific aortic stenosis. Nat Rev Dis Prim (2016) 0.79

Cardiac rehabilitation and mid-term follow-up after transcatheter aortic valve implantation. J Geriatr Cardiol (2014) 0.79

Update of transcatheter valve treatment. J Zhejiang Univ Sci B (2013) 0.79

Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update. Ont Health Technol Assess Ser (2013) 0.79

Long-term survival after surgical aortic valve replacement among patients over 65 years of age. Open Heart (2016) 0.79

Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery. J Thorac Cardiovasc Surg (2013) 0.78

Tissue-engineered heart valve with a tubular leaflet design for minimally invasive transcatheter implantation. Tissue Eng Part C Methods (2014) 0.78

The Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial. Trials (2013) 0.78

An analysis of real-world cost-effectiveness of TAVI in South Africa. Cardiovasc J Afr (2014) 0.78

Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). Am J Cardiol (2014) 0.78

Impact of severe left ventricular dysfunction on mid-term mortality in elderly patients undergoing transcatheter aortic valve implantation. J Geriatr Cardiol (2016) 0.78

Prevalence of blood type A and risk of vascular complications following transcatheter aortic valve implantation. Neth Heart J (2016) 0.77

Mid-term survival after transcatheter aortic valve implantation: Results with respect to the anesthetic management and to the access route (transfemoral versus transapical). Ann Card Anaesth (2015) 0.77

Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial. Surg Today (2014) 0.77

Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2015) 0.77

FTO Is Associated with Aortic Valve Stenosis in a Gender Specific Manner of Heterozygote Advantage: A Population-Based Case-Control Study. PLoS One (2015) 0.77

Pulmonary hypertension is a manifestation of congestive heart failure and left ventricular diastolic dysfunction in octogenarians with severe aortic stenosis. Pulm Circ (2015) 0.77

Incidence and severity of atherosclerotic cardiovascular artery disease in patients undergoing TAVI. Int J Cardiovasc Imaging (2015) 0.76

Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves. J Cardiothorac Surg (2016) 0.76

Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR). Indian Heart J (2013) 0.76

Aortic valve replacement vs. transcatheter aortic valve implantation: Patient selection. Ann Cardiothorac Surg (2012) 0.76

Transcatheter aortic valve implantation. F1000Prime Rep (2014) 0.76

A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI. Int J Cardiovasc Imaging (2016) 0.76

Risk and Outcome of Aortic Valve Surgery in the Transcatheter Valve Era: The Gender Aspect. Ann Thorac Cardiovasc Surg (2015) 0.75

Transcatheter aortic valve implantation: The transfemoral versus the transapical approach. Ann Cardiothorac Surg (2012) 0.75

Radiation Therapy-Induced Cardiovascular Disease Treated by a Percutaneous Approach. Case Rep Cardiol (2015) 0.75

Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.75

The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiol Ther (2012) 0.75

Recent advances in valvular heart disease. F1000Prime Rep (2013) 0.75

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)-a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open Heart (2016) 0.75

Valvular disease: TAVR outcomes maintained 2-years after the PARTNER trial. Nat Rev Cardiol (2012) 0.75

Balloon valvuloplasty as destination therapy in elderly with severe aortic stenosis: a cardiac catheterization study. J Geriatr Cardiol (2015) 0.75

3D Printing Model before and after Transcatheter Aortic Valve Implantation for a Better Understanding of the Anatomy of Aortic Root. Korean Circ J (2016) 0.75

A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis. Am J Cardiovasc Dis (2014) 0.75

On the Mechanics of Transcatheter Aortic Valve Replacement. Ann Biomed Eng (2016) 0.75

Transcatheter aortic valve replacement: indications and beyond the clinical trials. Tex Heart Inst J (2013) 0.75

Transcatheter aortic valves produce unphysiological flows which may contribute to thromboembolic events: An in-vitro study. J Biomech (2016) 0.75

Rapid Deployment Aortic Replacement (RADAR) Registry in Spain: a protocol. BMJ Open (2017) 0.75

Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras. Ann Thorac Surg (2015) 0.75

CT-angiography-based evaluation of the aortic annulus for prosthesis sizing in transcatheter aortic valve implantation (TAVI)-predictive value and optimal thresholds for major anatomic parameters. PLoS One (2014) 0.75

Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis. PLoS One (2015) 0.75

Transcatheter aortic valve implantation: from fantasy to reality. J Cardiothorac Surg (2014) 0.75

The Odyssey of TAVR from concept to clinical reality. Tex Heart Inst J (2014) 0.75

Does the transapical approach impair early recovery of systolic strain following transcatheter aortic valve replacement? Am J Cardiovasc Dis (2015) 0.75

Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). JACC Cardiovasc Interv (2015) 0.75

Impact of age on transcatheter aortic valve implantation outcomes: a comparison of patients aged ≤ 80 years versus patients > 80 years. J Geriatr Cardiol (2016) 0.75

Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review. CADTH Technol Overv (2013) 0.75

First transcatheter aortic valve implantation for severe pure aortic regurgitation in Asia. Singapore Med J (2014) 0.75

TAVR and SAVR: Current Treatment of Aortic Stenosis. Clin Med Insights Cardiol (2012) 0.75

Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency. Open Heart (2016) 0.75

Pseudomonas aeruginosa Infective Endocarditis Following Aortic Valve Implantation: A Note of Caution. Open Cardiovasc Med J (2016) 0.75

In-hospital resource utilization in surgical and transcatheter aortic valve replacement. BMC Cardiovasc Disord (2015) 0.75

A centenarian transcatheter aortic valve implantation case. J Geriatr Cardiol (2016) 0.75

Long-Term Outcomes of Conventional Aortic Valve Replacement in High-Risk Patients: Where Do We Stand? Ann Thorac Cardiovasc Surg (2016) 0.75

The beneficial effects of TAVI in mitral insufficiency. Cardiovasc Ultrasound (2015) 0.75

Transcatheter aortic valve replacement with the SAPIEN 3 valve: preparing the field for the final expansion. Cardiovasc Diagn Ther (2017) 0.75

Transcatheter aortic valve implantation in a young heart transplant recipient crossing the traditional boundaries. J Thorac Dis (2016) 0.75

Frailty is associated with delirium and mortality after transcatheter aortic valve implantation. Open Heart (2016) 0.75

BMJ shortlisted trial of Edwards-SAPIEN valve does not include all randomised patients. BMJ (2013) 0.75

Transapical aortic valve implantation in the presence of a mitral prosthesis. Ann Cardiothorac Surg (2012) 0.75

Catheter manipulation analysis for objective performance and technical skills assessment in transcatheter aortic valve implantation. Int J Comput Assist Radiol Surg (2016) 0.75

Echocardiography in transcatheter aortic valve implantation and mitral valve clip. Korean J Intern Med (2012) 0.75

Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience. World J Cardiol (2016) 0.75

Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Curr Treat Options Cardiovasc Med (2017) 0.75

Articles by these authors

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98

Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation (2010) 9.07

Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55

Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77

Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med (2015) 6.28

Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67

Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol (2010) 4.90

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol (2012) 4.77

Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med (2012) 4.55

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation (2004) 4.49

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (2012) 4.02

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (2015) 4.01

Submarine canyons: hotspots of benthic biomass and productivity in the deep sea. Proc Biol Sci (2010) 3.98

Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol (2006) 3.96

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85

Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85

Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2010) 3.79

Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol (2002) 3.68

Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol (2004) 3.67

Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation (2013) 3.64

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr (2003) 3.42

Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv (2011) 3.38

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37

American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr (2011) 3.32

Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29

Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol (2009) 3.26

Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA (2011) 3.19

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet (2013) 3.17

ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr (2011) 3.13

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA (2008) 3.09

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation (2006) 3.08

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA (2007) 3.07

Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation (2007) 3.05